When did Anika Therapeutics report Q3 2024 earnings?

Anika Therapeutics (ANIK) reported Q3 2024 earnings on October 31, 2024 before market open.

What were Anika Therapeutics's Q3 2024 revenue and EPS?

Anika Therapeutics reported revenue of $38.8M and eps of $-0.25 for Q3 2024.

Did Anika Therapeutics beat estimates in Q3 2024?

Revenue beat the consensus estimate of $29.0M by $9.8M. EPS missed the consensus estimate of $0.30 by $0.55.

Where can I find Anika Therapeutics's Q3 2024 SEC filings?

You can read the 10-Q periodic report (0001171843-24-005993) directly on SEC EDGAR. The filing index links above go to sec.gov.

Anika Therapeutics ANIK Q3 2024 earnings

Reported October 31, 2024 · Before market open

Revenue$38.8MBeat by $9.8M

EPS-$0.25Miss by $0.55

Revenue estimate$29.0M

EPS estimate$0.30

Next report

Jul 29, 2026 (Today)

Revenue estimate$29.2M

EPS estimate$0.03

View report

Financials

Q3 2024

Income statement

See full

Revenue$38.8M-6.5%

Net income-$29.9M-355%

Balance sheet

See full

Cash & equivalents$62.4M-11.7%

Total debt$27.5M+1.0%

Total equity$179.9M-33.5%

Total assets$231.4M-29.5%

Cash flow

See full

Operating cash flow$5.0M—

CapEx$1.2M+64.1%

Valuation & ratios

Valuation

as of 09/30/24

See full

Market cap$365.48M+34.1%

Enterprise value$330.65M+44.3%

P/S2.2×+0.6×

Profitability

See full

Net margin-59.4%-89.9pp

Returns & leverage

See full

Return on equity-43.3%-58.3pp

Debt / equity0.2×+0.1×

Current ratio5.3×-0.2×

Segments

By geography

See full

Europe$4.8M-11.5%

Other Location$4.2M-19.9%

Versus estimates

Revenue

Q1 2026$29.6MBeat by $1.5M Q4 2025$30.6MBeat by $1.7M Q3 2025$27.8MBeat by $17.0K Q2 2025$28.2MBeat by $685.7K Q1 2025$26.2MMiss by $1.9M Q4 2024-$1.3MMiss by $29.4M

Diluted EPS

Q1 2026$0.27Beat by $0.34 Q4 2025$0.31Beat by $0.44 Q3 2025$0.04Beat by $0.02 Q2 2025-$0.13In line Q1 2025-$0.06Miss by $0.15 Q4 2024-$0.03Miss by $0.02

Ask the moment Anika Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Anika Therapeutics report Q3 2024 earnings?: Anika Therapeutics (ANIK) reported Q3 2024 earnings on October 31, 2024 before market open.
What were Anika Therapeutics's Q3 2024 revenue and EPS?: Anika Therapeutics reported revenue of $38.8M and eps of $-0.25 for Q3 2024.
Did Anika Therapeutics beat estimates in Q3 2024?: Revenue beat the consensus estimate of $29.0M by $9.8M. EPS missed the consensus estimate of $0.30 by $0.55.
Where can I find Anika Therapeutics's Q3 2024 SEC filings?: You can read the 10-Q periodic report (0001171843-24-005993) directly on SEC EDGAR. The filing index links above go to sec.gov.